Downregulation of CSN 6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH 535 therapy
Publisher: John Wiley & Sons Inc
E-ISSN: 2045-7634|7|2|285-296
ISSN: 2045-7634
Source: Cancer Medicine, Vol.7, Iss.2, 2018-02, pp. : 285-296
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract